Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
소라페닙 치료 실패 후 세포독성화학요법으로 완전반응을 보인 폐전이를 동반한 간세포암 1예A Case of Hepatocellular Carcinoma with Pulmonary Metastasis Who Showed Complete Response by Cytotoxic Chemotherapy after Sorafenib Failure
- Other Titles
- A Case of Hepatocellular Carcinoma with Pulmonary Metastasis Who Showed Complete Response by Cytotoxic Chemotherapy after Sorafenib Failure
- Issue Date
- 2017
- Publisher
- 대한간암학회
- Keywords
- Hepatocellular carcinoma; Pulmonary metastasis; Cytotoxic chemotherapy; Sorafenib
- Citation
- 대한간암학회지, v.17, no.1, pp 72 - 76
- Pages
- 5
- Journal Title
- 대한간암학회지
- Volume
- 17
- Number
- 1
- Start Page
- 72
- End Page
- 76
- ISSN
- 2288-8128
2383-5001
- Abstract
- Hepatocellular carcinoma (HCC) is the 2nd most common cause of cancer related death in Korea and well-known malignancy with poor prognosis. Sorafenib is the first-line molecular targeted agent in patients with extra-hepatic spread of HCC. However, complete response is extremely rare in patients treated with sorafenib and the disease control rate is only 43%. We report a 53-year-old man with advanced HCC with pulmonary metastasis who showed complete response by cytotoxic chemotherapy with doxorubicin and cisplatin with relatively tolerable adverse effects after failure of treatment with sorafenib. (J Liver Cancer 2017;17:72-76)
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, SANG GYUNE
- College of Medicine (Department of Internal Medicine)